Quinolone Resistance Mechanisms in Pneumococci

Eliopoulos, George M.
May 2004
Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS350
Academic Journal
Quinolones are widely used in the treatment of respiratory infections, in large part because of their activity against Streptococcus pneumoniae and other commonly encountered respiratory tract pathogens. Pneumococcal isolates that are resistant to these "respiratory quinolones" have now begun to emerge. Resistance is attributable to mutations affecting the intracellular targets of these drugs, topoisomerase IV and DNA gyrase; drug efflux contributes to quinolone resistance in some isolates. Most commonly, strains fully resistant to the newer quinolones have one or more mutations affecting DNA gyrase and topoisomerase IV. Although various agents of this class exhibit selectivity in primarily targeting one or the other of these enzymes, the passage of isolates in the presence of any agent can result in selection of mutations affecting both enzymes. Quinolone resistance in S. pneumoniae has arisen in heterogeneous genetic backgrounds but, ominously, has now appeared in strains that are well adapted for regional and global transmission.


Related Articles

  • The Continuing Challenge of Lower Respiratory Tract Infections. Robert C.3 Moellering Jr. // Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS319 

    The discovery and clinical application of antibiotics has markedly changed the management of a wide variety of respiratory tract infections, including community acquired pneumonia (CAP), during the past half-century. One of the factors that could account for the persistence of problematic...

  • Interpreting Assays for the Detection of Streptococcus pneumoniae. Blaschke, Anne J. // Clinical Infectious Diseases;2011, Vol. 52 Issue suppl_4, pS331 

    Streptococcus pneumoniae is both an aggressive pathogen and a normal part of the human respiratory microbiome. Clinicians and microbiologists have struggled to develop tests that can identify pneumococcal respiratory infection and accurately distinguish colonization from invasive disease....

  • Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report). Tajima, Takeshi; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2013, Vol. 19 Issue 3, p510 

    We previously conducted nationwide surveillance of Streptococcus pneumoniae in 2000-2001 (period 1) and 2004 (period 2) and reported the findings. Subsequent surveillance surveys conducted in 2007 (period 3) and 2010 (period 4) are now reported. Bacterial strains were clinically isolated from...

  • Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance. Hjálmarsdóttir, Martha Á.; Pétursdóttir, Brynhildur; Erlendsdóttir, Helga; Haraldsson, Gunnsteinn; Kristinsson, Karl G. // Journal of Antimicrobial Chemotherapy (JAC);Aug2015, Vol. 70 Issue 8, p2203 

    Objectives The objective of this study was to investigate the prevalence of pilus islets [pilus islet 1 (PI-1) and pilus islet 2 (PI-2)] in pneumococcal isolates from healthy Icelandic preschool children attending day care centres, prior to the introduction of conjugated pneumococcal vaccine,...

  • Streptococcus pneumoniae. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p611 

    An encyclopedia entry for the term "streptococcus pneumoniae" is presented. It refers to a bacterium that causes respiratory tract infection.

  • Molecular Epidemiology of Streptococcus pneumoniae Isolates from Children with Recurrent Upper Respiratory Tract Infections. Korona-Glowniak, Izabela; Maj, Maciej; Siwiec, Radosław; Niedzielski, Artur; Malm, Anna // PLoS ONE;7/14/2016, Vol. 11 Issue 7, p1 

    A total of 125 isolates were recovered from adenoids and/or nasopharynx of 170 children aged 2 to 5 from south-east Poland; they had undergone adenoidectomy for recurrent and/or persistent symptoms of upper respiratory tract infections. Pneumococcal isolates were analyzed by phenotyping...

  • Antimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal. Ndiaye, Aissatou Gueye; Boye, Cheikh Saadbou; Hounkponou, Edwige; Gueye, Fatou Bintou; Badiane, Aida // Journal of Infection in Developing Countries;2009, Vol. 3 Issue 9, p660 

    Background : Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pyogenes, and Streptococcus pneumoniae are the most common causative agents of respiratory tract infections (RTIs). The increase in resistance to current antibacterial agents highlights the need to monitor the resistance...

  • Bacterial and Viral Throat Flora. Hable, Kathleen A.; Washington, John A.; Herrmann Jr., Ernest C. // Clinical Pediatrics;Apr1971, Vol. 10 Issue 4, p199 

    The article presents information on bacterial and viral throat flora. Acute upper respiratory tract infection was defined as illness having a sudden onset with rhinorrhea, pharyngitis, or cough indicating mucosal involvement of the nose, throat, or bronchi. A number of bacteria, including...

  • Telithromycin: A Ketolide Antibiotic for Treatment of Respiratory Tract Infections. Lonks, John R.; Goldmann, Donald A. // Clinical Infectious Diseases;6/1/2005, Vol. 40 Issue 11, p1657 

    Telithromycin, a recently approved ketolide antibiotic derived from 1 4-membered macrolides, is active against erythromycin- resistant pneumococci. Telithromycin has enhanced activity in vitro because it binds not only to domain V of ribosomal RNA (like macrolides do) but also to domain II....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics